As the world continues to grapple with the COVID-19 pandemic, a new variant known as Cicada has emerged, first spotted in South Africa in November 2024. This variant, classified as BA.3.2, belongs to the Omicron family and has now made its way to India, prompting health officials to take immediate action.
The Cicada variant is alarming due to its extensive genetic changes, boasting over 70 mutations compared to the original Wuhan strain. Notably, more than 50 of these mutations are found in the spike protein, which is crucial for the virus’s ability to infect human cells.
Symptoms associated with the Cicada variant include cough, extreme fatigue, runny nose, headache, sore throat, mild fever, muscle and joint pain, loss of taste or smell, night sweats, and rash. While these symptoms are concerning, it is important to note that the Cicada variant has not been confirmed to cause more severe illness than previous variants.
By January 2026, the variant had been detected in 22 countries, with three confirmed cases in the United States, all of whom recovered. The first confirmed case in the U.S. was reported in June 2025, highlighting the variant’s rapid spread.
Dr. Robert Hopkins Jr. commented on the situation, stating, “It is possible we will see Cicada become the dominant strain in the U.S., but that is by no means certain.” This uncertainty underscores the need for ongoing surveillance and research.
The CDC has emphasized the importance of monitoring the spread of BA.3.2, as it provides valuable insights into the potential for this new SARS-CoV-2 lineage to evade immunity from previous infections or vaccinations. As the Cicada variant continues to spread, health authorities in India are on high alert, implementing measures to track and contain its transmission.
Details remain unconfirmed regarding the variant’s impact on public health in India, but the situation is evolving rapidly. The emergence of the Cicada variant serves as a reminder that the pandemic is not over and that vigilance is crucial in the fight against COVID-19.
As communities brace for the implications of this new variant, the focus remains on vaccination efforts and public health measures to mitigate the spread of the virus. The coming weeks will be critical in determining how the Cicada variant affects the ongoing pandemic response in India and beyond.
